Avio S.p.A. Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw nearly 20% revenue growth, robust backlog, and strong progress in U.S. expansion and propulsion technology. Full-year guidance is confirmed, with rising defense demand and a busy launch schedule ahead.
Fiscal Year 2025
-
Record 2025 results with revenues up 23% and backlog exceeding EUR 2 billion, driven by strong defense and space demand. Outlook for 2026 remains positive, with cautious guidance due to geopolitical uncertainties and energy cost risks, but potential for further upside.
-
Record backlog and 26% revenue growth driven by strong order intake in space and defense, with EBITDA up despite energy costs. Capital increase supports U.S. expansion, and guidance for year-end is confirmed, with long-term targets showing significant growth in defense and U.S. markets.
-
H1 2025 saw 30% revenue and 24% EBITDA growth, with a €1.7B backlog and strong order momentum in both space and defense. A €400M capital increase will fund a major U.S. plant and European expansion, supporting a 10% annual revenue growth target and a shift toward defense.
-
Q1 2025 saw a 35% revenue increase, strong backlog, and successful launches, with guidance reaffirmed for 2025. Production ramp-up and defense order growth are on track, while new U.S. and European contracts and a U.S. plant support long-term expansion.
Fiscal Year 2024
-
Record revenues and backlog were achieved, driven by strong defense propulsion growth and successful Vega C and Ariane 6 launches. 2025 is expected to bring further revenue and EBITDA growth, with a focus on margin improvement and capacity expansion to meet rising defense and space demand.
-
Revenues grew 25% year-over-year, driven by defense propulsion and technology projects, with a record EUR 1.3 billion order backlog. 2024 guidance is confirmed, anticipating further growth from defense contracts and a busy 2025 launch schedule.
-
H1 2024 saw record backlog, 15% revenue growth, and strong defense propulsion gains. U.S. contracts and Ariane 6 success support a positive outlook, with guidance confirmed for 2024 and non-recurring costs set to decline.